logo

Comparable investigation in dopamine transporters with 99mTc-TRODAT-1 and 131I-FP-CIT SPECT in Parkinson's disease patients

RADIOCHEMISTRY, RADIOPHARMACEUTICALS AND NUCLEAR MEDICINE

Comparable investigation in dopamine transporters with 99mTc-TRODAT-1 and 131I-FP-CIT SPECT in Parkinson's disease patients

LIU Congjin
LIU Xingdang
ZHANG Guangming
LI Ding
WANG Jian
YANG Liqin
JIANG Yuping
Nuclear Science and TechniquesVol.18, No.4pp.232-236Published in print 20 Aug 2007
36100

Dopamine transporter (DAT) mediates the regulation of dopaminergic function. Two agents of TRODAT-1 and FP-CIT were observed in evaluating DAT change of Parkinson's disease (PD). The relationship between them was also evaluated. The results suggested that 99mTc-TRODAT-1 SPECT and 131I-FP-CIT SPECT may serve as sensitive and objective in vivo markers to reflect the severity of PD. The 99mTc-TRODAT-1 image is more accurate and clearer compared with 131I-FP-CIT.

99mTc-TRODAT-1 SPECT131I-FP-CIT SPECTParkinson's disease
References
[1] LIU Xingdang, GUO Liping, JIANG Chengchuan, et al. Shanghai Med J (in Chinese), 2002, 25(10): 607-609.
[2] LIU Xingdang, LIN Xiangtong, FANG Ping, et al. Chin J Nucl Med (in Chinese), 2000, 20(6): 285-286.
[3] Hughes A J, Daniel S E, Kilford L, et al. Neurol Neurosurg Psychiatry, 1992, 55: 181-184.
[4] Eshuis S A, Maquire R P, Leenders K L, et al. Eur J Nucl Med Mol Imaging, 2006, 33(2): 200-209.
[5] Booij J, Hemelaar J T G M, Speelman J D, et al. J Nucl Med, 1999, 40: 753-761.
[6] LIU Xingdang, LIN Xiangtong. Chin J Nucl Med (in Chinese), 2003, 23(3): 160-162.
[7] LIU Xingdang, FANG Ping, CHEN Zhengping, et al. Chin J Nucl Med (in Chinese), 2003, 23(1): 50-51.
[8] LIU Xingdang, LIN Xiangtong, KUANG Qinfang, et al. Asian J Nucl Med (in Chinese), 2002, 2(3): 180-183.
[9] LIU Xingdang, LIN Xiangtong. Chin J Nucl Med (in Chinese), 2000, 20(6): 263-265.
[10] LIU Xingdang, LIN Xiangtong, FANG Ping, et al. Chin J Nucl Med (in Chinese), 2000, 20(3): 140-141.